ADMA Biologics
ADMA
#3158
Rank
A$7.08 B
Marketcap
A$29.69
Share price
-0.25%
Change (1 day)
-0.39%
Change (1 year)

Market capitalization of ADMA Biologics (ADMA)

Market cap: A$7.08 Billion

As of December 2025 ADMA Biologics has a market cap of A$7.08 Billion. This makes ADMA Biologics the world's 3158th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ADMA Biologics from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025A$7.08 B6.84%
2024A$6.63 B342.37%
2023A$1.49 B19.03%
2022A$1.25 B230.72%
2021A$0.38 B58.83%
2020A$0.23 B-29.25%
2019A$0.33 B115.51%
2018A$0.15 B-15.61%
2017A$0.18 B103.56%
2016A$91.53 M-22.87%
2015A$0.11 B-6.42%
2014A$0.12 B56.08%
2013A$81.25 M

End of Day market cap according to different sources

On Dec 15th, 2025 the market cap of ADMA Biologics was reported to be:

A$7.06 Billion
by Nasdaq info icon info icon
A$7.08 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novavax
NVAX
A$1.60 B-77.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$13.60 B 91.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A$72.17 M-98.98%๐Ÿ‡บ๐Ÿ‡ธ USA